Brian G Atwood - Net Worth and Insider Trading
Brian G Atwood Net Worth
The estimated net worth of Brian G Atwood is at least $42 Million dollars as of 2024-04-23. Brian G Atwood is the Director of Five Prime Therapeutics Inc and owns about 1,092,152 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $42 Million. Brian G Atwood is also the Director, 10% Owner of OpGen Inc and owns about 255 shares of OpGen Inc (OPGN) stock worth over $156. Details can be seen in Brian G Atwood's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian G Atwood has not made any transactions after 2015-05-08 and currently still holds the listed stock(s).
Transaction Summary of Brian G Atwood
Brian G Atwood Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian G Atwood owns 17 companies in total, including Atreca Inc () , Clovis Oncology Inc () , and PhaseRx Inc () among others .
Click here to see the complete history of Brian G Atwood’s form 4 insider trades.
Insider Ownership Summary of Brian G Atwood
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Atreca Inc | 2019-06-19 | director | |
Clovis Oncology Inc | 2016-06-09 | director | |
PhaseRx Inc | 2017-05-25 | director & 10 percent owner | |
OpGen Inc | 2015-05-08 | director | |
Veracyte Inc | 2013-10-29 | director & 10 percent owner | |
Flexion Therapeutics Inc | 2016-06-08 | 10 percent owner | |
Glaukos Corp | 2015-06-24 | 10 percent owner | |
Immune Design Corp | 2016-01-04 | director | |
Five Prime Therapeutics Inc | 2015-06-12 | director | |
Inogen Inc | 2014-09-09 | 10 percent owner | |
Second Sight Medical Products Inc | 2014-11-18 | 10 percent owner | |
Insulet Corp | 2007-05-14 | 10 percent owner | |
Paratek Pharmaceuticals Inc | 2006-05-09 | 10 percent owner | |
Alexza Pharmaceuticals Inc | 2006-03-13 | other: Former 10% Holder | |
eFFECTOR Therapeutics Inc | 2021-01-07 | director | |
Phoenix Biotech Acquisition Corp | 2021-10-05 | director | |
Vivani Medical Inc | 2014-11-18 | 10 percent owner |
Brian G Atwood Latest Holdings Summary
Brian G Atwood currently owns a total of 2 stocks. Among these stocks, Brian G Atwood owns 1,092,152 shares of Five Prime Therapeutics Inc (FPRX) as of September 23, 2013, with a value of $42 Million and a weighting of 100%. Brian G Atwood also owns 255 shares of OpGen Inc (OPGN) as of May 8, 2015, with a value of $156 and a weighting of 0%.
Latest Holdings of Brian G Atwood
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FPRX | Five Prime Therapeutics Inc | 2013-09-23 | 1,092,152 | 38.00 | 41,501,776 |
OPGN | OpGen Inc | 2015-05-08 | 255 | 0.61 | 156 |
Holding Weightings of Brian G Atwood
Brian G Atwood Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian G Atwood has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the acquisition of 76,923 shares on September 23, 2013, which cost Brian G Atwood around $999,999.
According to the SEC Form 4 filings, Brian G Atwood has made a total of 0 transactions in OpGen Inc (OPGN) over the past 5 years. The most-recent trade in OpGen Inc is the acquisition of 41 shares on May 8, 2015, which cost Brian G Atwood around $2 Million.
Insider Trading History of Brian G Atwood
- 1
Brian G Atwood Trading Performance
GuruFocus tracks the stock performance after each of Brian G Atwood's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian G Atwood is -7.87%. GuruFocus also compares Brian G Atwood's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian G Atwood within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Brian G Atwood's insider trading performs compared to the benchmark.
Performance of Brian G Atwood
Average Return
Outperforming Transactions
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 3.65 | -7.87 | -4.43 | -40.95 | -17.8 | -7.12 |
Relative Return to S&P 500(%) | 3.21 | -10.67 | -8.87 | -47.81 | -24.4 | -15.33 |
Brian G Atwood Ownership Network
Ownership Network List of Brian G Atwood
Ownership Network Relation of Brian G Atwood
Brian G Atwood Owned Company Details
What does Atreca Inc do?
Who are the key executives at Atreca Inc?
Brian G Atwood is the director of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .
Atreca Inc () Insider Trades Summary
Over the past 18 months, Brian G Atwood made no insider transaction in Atreca Inc (). Other recent insider transactions involving Atreca Inc () include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .
In summary, during the past 3 months, insiders sold 20,788 shares of Atreca Inc () in total and bought 0 shares, with a net sale of 20,788 shares. During the past 18 months, 353,058 shares of Atreca Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.
Atreca Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Atreca Inc Insider Transactions
Brian G Atwood Mailing Address
Above is the net worth, insider trading, and ownership report for Brian G Atwood. You might contact Brian G Atwood via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.